Barrett Katz Viridian Therapeutics, Inc.\De (VRDN) insider trading activity

Barrett Katz is Chief Medical Officer of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 0 shares of VRDN, which is worth approximately $0. The most recent transaction as insider was on Jan 17, 2023, when has been sold 24,853 shares (Common Stock) at a price of $37.21 per share, resulting in proceeds of $924,780. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Barrett Katz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 17 2023	SELL Open market or private sale	$924,780 $37.21 p/Share	24,853 Reduced 100.0%	0 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	$572,364 $23.03 p/Share	24,853 Added 50.0%	24,853 Common Stock
Jan 13 2023	SELL Open market or private sale	$153,480 $37.01 p/Share	4,147 Reduced 100.0%	0 Common Stock
Jan 13 2023	BUY Exercise of conversion of derivative security	$95,505 $23.03 p/Share	4,147 Added 50.0%	4,147 Common Stock
Jan 10 2023	SELL Open market or private sale	$1,672,408 $35.3 p/Share	47,377 Reduced 100.0%	0 Common Stock
Jan 10 2023	BUY Exercise of conversion of derivative security	$1,091,092 $23.03 p/Share	47,377 Added 50.0%	47,377 Common Stock
Jan 09 2023	SELL Open market or private sale	$417,063 $33.04 p/Share	12,623 Reduced 100.0%	0 Common Stock
Jan 09 2023	BUY Exercise of conversion of derivative security	$290,707 $23.03 p/Share	12,623 Added 50.0%	12,623 Common Stock

Barrett Katz

Chief Medical Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRDN shares.

Notify only if

Value

Insider Trading

Get notified when an Viridian Therapeutics, Inc.\De insider buys or sells VRDN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Viridian Therapeutics, Inc.\DE

Track Activities on VRDN

Account